FTI Consulting (FTI Consulting Management Solutions Limited)

Lobbying Organisation FTI Consulting

Date published 21 Sep, 2020

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 May, 2020 to 31 Aug, 2020

Specific Details GW Pharmaceuticals sent a letter to Minister Stephen Donnelly and Deputy Minister Frank Feighan to request a meeting to discuss cannabinoid science and GW Pharmaceuticals.

Intended results Secure meeting with Minister Stephen Donnelly or Department of Health officials to discuss cannabinoid science and GW Pharmaceuticals.

Name of person primarily responsible for lobbying on this activity Chris Tovey

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? Yes

Client(s)

Client 1

Company name GW Pharmaceuticals

CRO number (if applicable)

Company address Sovereign House Vision Park, Histon Cambridge CB24 9BZ United Kingdom

Main business or activity Health

Company website www.gwpharm.com

Contact email address info@gwpharm.com

Contact phone number +44 1223 266800

Contact address

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Letter (1)

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Stephen Donnelly Minister (Department of Health)

Frank Feighan Minister of State (Department of Health)